Abstract
Objective
The DETECT algorithm was developed for screening patients with SSc at high risk of pulmonary arterial hypertension (PAH). We evaluated the impact of this algorithm in a SSc population.Methods
Patients from the unselected, prospective Oslo University Hospital SSc study were divided into the Early and DETECT cohorts, respectively, depending on whether an incident right heart catheterization (RHC) was performed before (2009-13) or after (2014-17) the DETECT algorithm was instituted. A PAH diagnosis and patient risk stratification (low, intermediate and high risk) were performed according to 2015 European Society of Cardiology guidelines.Results
At the time of the incident RHC, PAH frequency was similar between the DETECT (15/84 with PAH; 18%) and Early (16/77; 21%) cohorts, but more patients had borderline pulmonary hypertension (PH) in the DETECT (31%) than in the Early (17%) cohort. PAH risk levels were distributed differently. In the DETECT cohort, 27% and 27% were at low and high risk, respectively, at the time of PAH diagnosis. In the Early cohort, 19 and 44% were at low and high risk, respectively. A follow-up RHC, performed after [mean (SD)] 2.4 (1.8) years, showed that 39% of patients with borderline PH in the Early cohort had developed PAH.Conclusion
The DETECT algorithm did not alter PAH incidence in this unselected SSc population. However, it appeared to affect the risk distribution at the time of PAH diagnosis and increased the frequency of borderline PH cases. These findings may translate into novel opportunities for earlier PAH treatment and, possibly, prevention.Full text links
Read article at publisher's site: https://doi.org/10.1093/rheumatology/kex435
Read article for free, from open access legal sources, via Unpaywall: https://academic.oup.com/rheumatology/article-pdf/57/3/480/23922677/kex435.pdf
References
Articles referenced by this article (35)
Title not supplied
2012
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.
Ann Rheum Dis, (10):1809-1815 2010
MED: 20551155
Mortality and survival in systemic sclerosis: systematic review and meta-analysis.
Semin Arthritis Rheum, (2):208-219 2014
MED: 24931517
Survival and causes of death in an unselected and complete cohort of Norwegian patients with systemic sclerosis.
J Rheumatol, (7):1127-1133 2013
MED: 23637316
Survival in patients with pulmonary arterial hypertension associated with systemic sclerosis from a Swedish single centre: prognosis still poor and prediction difficult.
Scand J Rheumatol, (2):127-132 2010
MED: 20858146
Systemic sclerosis-associated pulmonary arterial hypertension.
Chest, (4):1346-1356 2013
MED: 24081346
Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival.
Eur Respir J, (5):1271-1282 2013
MED: 23397301
Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies.
Arthritis Rheum, (8):2456-2464 2011
MED: 21538327
Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension.
Arthritis Res Ther, (1):122 2017
MED: 28576149
Show 10 more references (10 of 35)
Citations & impact
Impact metrics
Article citations
Accuracy of brain natriuretic peptide and N-terminal brain natriuretic peptide for detecting paediatric pulmonary hypertension: a systematic review and meta-analysis.
Ann Med, 56(1):2352603, 16 May 2024
Cited by: 0 articles | PMID: 38753384 | PMCID: PMC11100439
Review Free full text in Europe PMC
Sildenafil Versus Placebo for Early Pulmonary Vascular Disease in Scleroderma (SEPVADIS): protocol for a randomized controlled trial.
BMC Pulm Med, 24(1):211, 30 Apr 2024
Cited by: 0 articles | PMID: 38689245 | PMCID: PMC11061972
Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertension.
Front Immunol, 13:991743, 23 Sep 2022
Cited by: 6 articles | PMID: 36211384 | PMCID: PMC9541617
Serum markers of cardiac complications in a systemic sclerosis cohort.
Sci Rep, 12(1):4661, 18 Mar 2022
Cited by: 6 articles | PMID: 35304587 | PMCID: PMC8933514
Pulmonary hypertension phenotypes in patients with systemic sclerosis.
Eur Respir Rev, 30(161):210053, 17 Aug 2021
Cited by: 22 articles | PMID: 34407977 | PMCID: PMC9517999
Review Free full text in Europe PMC
Go to all (13) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Application of the DETECT algorithm for detection of risk of pulmonary arterial hypertension in systemic sclerosis: data from a Czech tertiary centre.
Rheumatology (Oxford), 55(1):109-114, 28 Aug 2015
Cited by: 12 articles | PMID: 26320140
Screening for pulmonary arterial hypertension in an unselected prospective systemic sclerosis cohort.
Eur Respir J, 49(5):1602275, 11 May 2017
Cited by: 22 articles | PMID: 28495691
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.
Ann Rheum Dis, 73(7):1340-1349, 18 May 2013
Cited by: 354 articles | PMID: 23687283 | PMCID: PMC4078756
Performance of screening algorithms in systemic sclerosis-related pulmonary arterial hypertension: a systematic review.
Intern Med J, 43(7):751-760, 01 Jul 2013
Cited by: 5 articles | PMID: 23611651
Review